Skip to main content
OpenTrials
Completed

NCT Number: NCT06180694

Reminiscence Therapy in Individuals With Dementia

This research will be carried out with the aim of determining the effect of reminiscence therapy applied to individuals with dementia on cognitive functions, anxiety, depression and activities of daily living.

The research will be conducted with a pre-test post-test single group, quasi-experimental research design.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dementia Brain Diseases Central Nervous System Diseases Mental Disorders Nervous System Diseases Neurocognitive Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Merve Çayır Yılmaz

Amasya, Turkey (Türkiye)

About this study

Dementia; It is a disease that requires intensive use of health services, has a high care burden, and has medical, social, psychological and economic burdens for the patient, family and society. Dementia is characterized by many disorders in cognitive functions, especially memory, thought and social skills. Progressive disorders in cognitive functions cause behavioral changes, decrease in activities of daily living, and neuropsychiatric symptoms such as anxiety and depression.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being diagnosed with mild to moderate dementia according to DSM-5 criteria (whether individuals have an official diagnosis of neurocognitive disorder according to DSM-5 criteria and their medical diagnosis will be verified from the health records at the institution),
  • Getting a score between 13-23 for the educated (literate) and 10-23 for the uneducated (illiterate) on the mini mental state examination,
  • Being 65 years of age or older,
  • Being able to communicate,
  • No vision or hearing problems,
  • Consent to participate in the research.

Exclusion criteria

  • Getting a score below 13 and above 23 for the educated (literate) and below 10 and above 23 for the uneducated (illiterate) from the mini mental state examination,
  • Having an acute illness that prevents participation in intervention sessions,
  • Having serious sensory and physical limitations that prevent participation,
  • Having severe neuropsychiatric symptoms (agitation, psychosis, apathy, uncontrolled delirium, etc.),
  • Having a traumatic life history,
  • Having recently participated in a similar program.

Treatment and study plan

Reminiscence therapy

Other

Reminiscence therapies will be applied to individuals with dementia in 45-minute sessions once a week for 8 weeks.

Primary outcomes

  1. Change from Baseline in Cognitive Status on the Standardized Mini Mental Test (SMMT) at Week 8

    Time frame: Baseline and week 8

    SMMT, which allows assessing cognitive status, is the most frequently used and easily applied test in dementia screening. The scale is evaluated out of 30 points in total. For SMMT, scores of 23/24 are considered the cutoff score for dementia, but traditionally scores between 24 and 30 are considered normal. A score below 24 indicates cognitive impairment, between 18 and 23 points is considered mild dementia, between 13 and 17 points is considered moderate dementia, and below 12 points is considered severe dementia. Change = (Week 8 Score-Baseline Score)

  2. Change from Baseline in Anxiety Symptoms on Geriatric Anxiety Scale (GAS)

    Time frame: Baseline and week 8

    GAS,developed for the elderly, is a 30-item scale that has somatic, cognitive and affective subscales and monitors anxiety symptoms. The total score on the scale varies between 0-75. A high score indicates a high level of anxiety.Change = (Week 8 Score-Baseline Score)

  3. Change from Baseline in Depressive Symptoms on Geriatric Depression Scale Short Form (GDS-SF)

    Time frame: Baseline and week 8

    GDS-SF, is a scale consisting of 15 questions that questions the emotional state of elderly individuals. The cut-off point of the scale is 7 points and above. Scores between 0 and 4 indicate no depressive symptoms, scores between 5 and 8 indicate mild depressive symptoms, scores between 9 and 11 indicate moderate depressive symptoms, and scores of 12 and above indicate severe depressive symptoms. Change = (Week 8 Score-Baseline Score)

  4. Change from Baseline in Patient's Dependency on Basic Self-Care Behaviors on Katz's Activities of Daily Living Index (KADLI)

    Time frame: Baseline and week 8

    KADLI, evaluates the patient's dependence on basic self-care behaviors that are required to live and are expected to do every day. The scale evaluates the degree of dependency in basic daily living activity parameters, including information on bathing, dressing, toileting, transfer, continence and nutrition. Scoring of the index ranges from 0 to 6, and a patient with a score of 6 is considered independent, and a patient with a score of 0 is considered fully dependent. Change = (Week 8 Score-Baseline Score)

Sponsors and collaborators

Lead sponsor

Amasya University

Other

Collaborators

  • The Scientific and Technological Research Council of Turkey

Registry information

Official study title

Reminiscence Therapy Applied to Individuals With Dementia

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Dec 22, 2023
Registry last updated
Apr 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.